Helmink Beth A, Snyder Rebecca A, Idrees Kamran, Merchant Nipun B, Parikh Alexander A
Division of Surgical Oncology, Vanderbilt University Medical Center, 597 PRB, 2220 Pierce Avenue, Nashville, TN 37232, USA.
Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, 1400 Pressler Street, Unit Number: 1484, Houston, TX 77030, USA.
Surg Oncol Clin N Am. 2016 Apr;25(2):287-310. doi: 10.1016/j.soc.2015.11.008. Epub 2016 Feb 17.
Successful surgical resection offers the only chance for cure in patients with pancreatic cancer. However, pancreatic resection is feasible in less than 20% of the patients. In this review, the current state of surgical management of pancreatic cancer is discussed. The definition of resectability based on cross-sectional imaging and the technical aspects of surgery, including vascular resection and/or reconstruction, management of aberrant vascular anatomy and extent of lymphadenectomy, are appraised. Furthermore, common pancreatic resection-specific postoperative complications and their management are reviewed.
成功的手术切除为胰腺癌患者提供了唯一的治愈机会。然而，不到20%的患者可行胰腺切除术。在本综述中，讨论了胰腺癌手术治疗的现状。基于横断面成像的可切除性定义以及手术的技术方面，包括血管切除和/或重建、异常血管解剖的处理以及淋巴结清扫范围，均进行了评估。此外，还回顾了常见的胰腺切除术后特异性并发症及其处理方法。
